Search Results - "Spring LM"

SA33 Real-World Cardiac Safety of Anti-HER2 Therapies in Elderly Patients with HER2+/HR-Metastatic Breast Cancer: A Retrospective Cohort Study Using SEER-Medicare DATA 2012-2016.

Authors: Ou, Z Nohria, A Spring, LM et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS610-S610. 1p.

Current landscape of sequencing ADCs in metastatic breast cancer.

Authors: McLaughlin S Ravani LV Moy B et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Dec 17; Vol. 17, pp. 17588359251396656. Date of Electronic Publication: 2025 Dec 17 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe Trial.

Authors: Tarantino P Li T Ogayo ER et al.

Source: JAMA oncology [JAMA Oncol] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Selection biases in the systematic collection of breast biobank specimens.

Authors: Bar Y Wang GX Gioia GE et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Aug 01; Vol. 11 (1), pp. 83. Date of Electronic Publication: 2025 Aug 01.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

Authors: Wander SA Lloyd MR Keenan JC et al.

Source: The Lancet. Oncology [Lancet Oncol] 2026 May; Vol. 27 (5), pp. 580-591.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer.

Authors: Wu B Thant W Bitman E et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Apr 03; Vol. 14 (4). Date of Electronic Publication: 2026 Apr 03.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

Authors: Spring LM Scarpetti L Medford AJ et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Jan 07; Vol. 11 (1), pp. 2. Date of Electronic Publication: 2025 Jan 07.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child.

Authors: Keenan JC Medford AJ Dai CS et al.

Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Jun; Vol. 24 (6), pp. 397-405. Date of Electronic Publication: 2024 Apr 26.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.

Authors: Medford AJ Velimirovic M Gefen Y et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Aug; Vol. 212 (3), pp. 437-447. Date of Electronic Publication: 2025 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects.

Authors: Rojas K Spring LM O'Riordan L et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2023 Oct; Vol. 30 (10), pp. 5951-5961. Date of Electronic Publication: 2023 Jul 26.

Publication Type: Review; Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study).

Authors: Isakoff SJ Said MR Kwak AH et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jun; Vol. 199 (3), pp. 501-509. Date of Electronic Publication: 2023 Apr 27.

Publication Type: Clinical Trial; Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

Authors: Abelman RO Wu B Barnes H et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 May 15; Vol. 31 (10), pp. 1966-1974.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series.

Authors: Brett JO Ritterhouse LL Newman ET et al.

Source: The oncologist [Oncologist] 2023 Feb 08; Vol. 28 (2), pp. 172-179.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.

Authors: Medford AJ Oshry L Boyraz B et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Jan 30; Vol. 15, pp. 17588359231152844. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.

Authors: McLaughlin S Nakajima E Bar Y et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Jan 10; Vol. 15, pp. 17588359221146133. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer.

Authors: Wu B Thant W Bitman E et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Dec 05. Date of Electronic Publication: 2024 Dec 05.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.

Authors: Dias-Santagata D Heist RS Bard AZ et al.

Source: The oncologist [Oncologist] 2022 Nov 03; Vol. 27 (11), pp. 930-939.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.

Authors: Denault E Nakajima E Naranbhai V et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Aug 22; Vol. 14, pp. 17588359221119370. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer.

Authors: Waks AG Desai NV Li T et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2022 May 10; Vol. 8 (1), pp. 63. Date of Electronic Publication: 2022 May 10.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population.

Authors: Beyerlin K Jimenez R Zangardi M et al.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Dec; Vol. 27 (8), pp. 1883-1890. Date of Electronic Publication: 2020 Nov 05.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE